The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Efthymios N. Deliargyris
Showing 1-4 of 4 articles
Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials
Vaduganathan M,
Harrington R,
Stone G,
Steg P,
Gibson CM,
Hamm C,
Price M,
Lopes R,
Leonardi S,
Deliargyris E,
Prats J,
Mahaffey K,
White H,
Bhatt D
February 2, 2018 | 10.4244/EIJ-D-17-00723
Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study
van Geuns R,
Sideris G,
van Royen N,
El Mahmoud R,
Diletti R,
Sollier C,
Garot J,
Van Der Hoeven N,
Cortese B,
Ding L,
Lechthaler I,
Deliargyris E,
Anthopoulos P,
Drouet L
August 4, 2017 | 10.4244/EIJ-D-17-00307
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials
Geisler T,
Müller K,
Karathanos A,
Bocksch W,
Gawaz M,
Deliargyris E,
Bernstein D,
Lincoff A,
Mehran R,
Dangas G,
Stone G
May 20, 2014 | 10.4244/EIJV10I1A16
Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study
Hamon M,
Rao S,
Steg G,
Valgimigli M,
Verheugt F,
Marso S,
Gershlick A,
Wang Y,
Deliargyris E
August 24, 2012 | 10.4244/EIJV8I4A76
1
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke